These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 25085878)
1. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance. Flacher V; Tripp CH; Mairhofer DG; Steinman RM; Stoitzner P; Idoyaga J; Romani N EMBO Mol Med; 2014 Sep; 6(9):1191-204. PubMed ID: 25085878 [TBL] [Abstract][Full Text] [Related]
2. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses. Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181 [TBL] [Abstract][Full Text] [Related]
3. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. Flacher V; Tripp CH; Stoitzner P; Haid B; Ebner S; Del Frari B; Koch F; Park CG; Steinman RM; Idoyaga J; Romani N J Invest Dermatol; 2010 Mar; 130(3):755-62. PubMed ID: 19890348 [TBL] [Abstract][Full Text] [Related]
4. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens. Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175 [TBL] [Abstract][Full Text] [Related]
5. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1. van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391 [TBL] [Abstract][Full Text] [Related]
6. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells. Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044 [TBL] [Abstract][Full Text] [Related]
8. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus. Seneschal J; Jiang X; Kupper TS J Invest Dermatol; 2014 Mar; 134(3):686-694. PubMed ID: 24126845 [TBL] [Abstract][Full Text] [Related]
9. Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization. Elnekave M; Furmanov K; Nudel I; Arizon M; Clausen BE; Hovav AH J Immunol; 2010 Sep; 185(6):3463-71. PubMed ID: 20713888 [TBL] [Abstract][Full Text] [Related]
10. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors. Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252 [TBL] [Abstract][Full Text] [Related]
11. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Ritter U; Meissner A; Scheidig C; Körner H Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423 [TBL] [Abstract][Full Text] [Related]
12. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. Brewig N; Kissenpfennig A; Malissen B; Veit A; Bickert T; Fleischer B; Mostböck S; Ritter U J Immunol; 2009 Jan; 182(2):774-83. PubMed ID: 19124720 [TBL] [Abstract][Full Text] [Related]
13. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy. Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477 [TBL] [Abstract][Full Text] [Related]
14. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Romani N; Clausen BE; Stoitzner P Immunol Rev; 2010 Mar; 234(1):120-41. PubMed ID: 20193016 [TBL] [Abstract][Full Text] [Related]
15. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Idoyaga J; Suda N; Suda K; Park CG; Steinman RM Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1524-9. PubMed ID: 19168629 [TBL] [Abstract][Full Text] [Related]
16. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446 [TBL] [Abstract][Full Text] [Related]
17. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets. Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520 [TBL] [Abstract][Full Text] [Related]
18. Sustained in vivo depletion of splenic langerin(+) CD8α(+) dendritic cells is well-tolerated by lang-DTREGFP mice. Prendergast KA; Osmond TL; Ochiai S; Hermans IF; Kirman JR J Immunol Methods; 2014 Apr; 406():104-9. PubMed ID: 24556588 [TBL] [Abstract][Full Text] [Related]
19. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines. Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444 [TBL] [Abstract][Full Text] [Related]
20. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation. van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]